Delivery Order SPE2DB20D2014-SPE2DB24FA85M
Award Date
1/22/24
Potential Completion Date
1/23/24
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,732.07, is for the supply of 4562705177 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The $6,125.48 firm fixed-price contract has an ultimate completion date of August 24, 2023. This order is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,235.25, is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract is a firm fixed price delivery order with a ceiling value of $6,144.50 and a period of performance through August 20, 2024. The award is not associated with a set-aside designation, indicating open competition. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,206.40 firm-fixed-price contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a specialty pharmaceutical product. The order has a completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4558564147 - Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a firm fixed price of $8,635.43 and an ultimate completion date of September 23, 2022. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, a critical diabetes medication. The contract has a ceiling value of $17,635.17 and runs through March 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide Insulin Aspart 100 Unit/mL Pen 3mL. The contract has a potential value of $28,673.28 and a completion date of January 31, 2024. This delivery order is issued under a single award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through December 31, 2025. The IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4563335060 - Insulin Aspart 100 Unit/mL Pen 3mL. The fixed-price contract has a ceiling value of $4,296.99 and a completion date of January 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,513.53, is for the delivery of 4563348414 INSULIN ASPART 100 UNIT/ML PEN 3ML. The contract has an ultimate completion date of January 18, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...